NEW YORK, July 24, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018http://www.reportlinker.com/p0862093/In-Vitro-Diagnostics-IVD---Emerging-Countries-Brazil-Russia-India-China-Opportunity-Assessment-Competitive-Landscape-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData's new report, "In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the In Vitro Diagnostics (IVD) market in emerging countries. The report provides market landscape, competitive landscape and market trends information on the IVD market in emerging countries. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

-Key geographies covered include the China, India, Brazil and Russia. - Key segments covered include Immuno Chemistry, Infectious Immunology, Clinical Chemistry, Haematology, Histology and Cytology, Genetic Testing and Microbiology Culture. - Annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018. Company shares data for 2011. - Qualitative analysis of key market trends, market drivers, and restraints within IVD market in emerging countries. - The report also covers information on the leading market players and the competitive landscape. - Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sysmex Corporation, Transasia Bio-Medicals Ltd. and Beckman Coulter.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the IVD market in emerging countries. - Design and develop your product development, marketing and sales strategies. - Develop market-entry and market expansion strategies. - Identify key players best positioned to take advantage of the emerging market opportunities. - Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return. - What's the next big thing in the IVD market in emerging countries? Identify, understand and capitalize. - Make more informed business decisions from the insightful and in-depth analysis of the IVD market in emerging countries and the factors shaping it.

See the original post:
In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive ...